Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2020-12-17 | 2021-01-21 | 130285 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2021-03-18 | 2021-03-25 | 135946 |
TEVA-MEXILETINE | 100MG | CAPSULE | Resolved | 2023-06-19 | 2023-11-03 | 195542 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2023-10-12 | 2023-11-03 | 206895 |
TEVA-MEXILETINE | 100MG | CAPSULE | Resolved | 2020-02-21 | 2020-07-23 | 106922 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2020-03-26 | 2020-06-18 | 109568 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2017-08-21 | 2018-02-21 | 19978 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-06-08 | 2023-10-03 | 194100 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-11-30 | 2024-01-19 | 211979 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2024-05-09 | 2024-09-05 | 227480 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167246 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195509 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2023-10-05 | 2024-07-03 | 206407 |
TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-06-18 | 2019-07-31 | 86902 |
TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-17 | 2024-11-28 | 240522 |
TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-09-05 | 2019-10-04 | 93137 |
TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110709 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-12-19 | 2025-03-27 | 246104 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |